ISDA

Deposition Date 2014-08-27

Release Date 2014-12-03

Last Version Date 2024-01-10

Entry Detail

PDB ID:

4W9Q

Keywords:

ISOMERASE

Title:

The Fk1 domain of FKBP51 in complex with (1S,5S,6R)-10-[(3,5-dichlorophenyl)sulfonyl]-3-[2-(3,4-dimethoxyphenoxy)ethyl]-5-ethyl-3,10-diazabicyclo[4.3.1]decan-2-one

Biological Source:

Source Organism:

Homo sapiens (Taxon ID: 9606)

Host Organism:

Escherichia coli BL21(DE3)

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

1.08 Å

R-Value Free:

0.16

R-Value Work:

0.15

R-Value Observed:

0.15

Space Group:

P 21 21 21

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Molecule:Peptidyl-prolyl cis-trans isomerase FKBP5
Gene (Uniprot):FKBP5
Mutations:yes
Chain IDs:A
Chain Length:128
Number of Molecules:1
Biological Source:Homo sapiens

UniProt ID:Q13451 Pfam ID:PF00254

Ligand Molecules

3JP

Primary Citation

Rational Design and Asymmetric Synthesis of Potent and Neurotrophic Ligands for FK506-Binding Proteins (FKBPs).

Pomplun, S, Wang, Y, Kirschner, A, Kozany, C, Bracher, A, Hausch, F, Bracher, A, Kozany, C, Thost, A.-K, Hausch, F.Show

Angew.Chem.Int.Ed.Engl. 54 345 348 (2015)

PMID: 25412894 DOI: 10.1002/anie.201408776

Abstact

To create highly efficient inhibitors for FK506-binding proteins, a new asymmetric synthesis for pro-(S)-C(5) -branched [4.3.1] aza-amide bicycles was developed. The key step of the synthesis is an HF-driven N-acyliminium cyclization. Functionalization of the C(5) moiety resulted in novel protein contacts with the psychiatric risk factor FKBP51, which led to a more than 280-fold enhancement in affinity. The most potent ligands facilitated the differentiation of N2a neuroblastoma cells with low nanomolar potency.

Legend

Protein

Chemical

Disease

Primary Citation of related structures